AMGEN INC - Common Stock (AMGN)

Historical Holders from Q1 2014 to Q4 2025

Symbol
AMGN on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
538,607,950
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
421,944,206
Holdings value
$119,042,096,234
% of all portfolios
0.1%
Number of holders
2,776
Number of buys
1,219
Number of sells
1,277
Average buys %
+0.01%
Average sells %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AMGEN INC - Common Stock (AMGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10% $15,819,992,707 53,860,795 The Vanguard Group 29 Aug 2025
BlackRock, Inc. 7.6% $12,720,845,086 40,830,830 BlackRock, Inc. 31 Mar 2025
As of 30 Sep 2025 AMGEN INC - Common Stock (AMGN) has 2,776 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 421,944,206 shares of 538,607,950 outstanding shares and own 78% of the company stock as of 30 Sep 2025.

Top 25 institutional shareholders of AMGEN INC - Common Stock (AMGN) own 54% of the company based on 13F filings as of 30 Sep 2025

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 10% 53,876,851 +0.31% 0.23% $15,204,047,353
BlackRock, Inc. 8.5% 46,034,432 -1.2% 0.23% $12,990,916,763
STATE STREET CORP 5.4% 29,304,093 -0.18% 0.29% $8,269,615,045
Capital International Investors 3.6% 19,192,995 +1.5% 0.87% $5,414,295,672
Capital World Investors 3.5% 18,795,474 +11% 0.72% $5,303,577,510
MORGAN STANLEY 3% 15,910,525 -1.7% 0.27% $4,489,951,105
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2.5% 13,550,612 +5.1% 0.61% $3,823,982,706
GEODE CAPITAL MANAGEMENT, LLC 2.5% 13,267,515 +1.9% 0.24% $3,729,547,923
PRIMECAP MANAGEMENT CO/CA/ 1.8% 9,707,609 -8.7% 2.1% $2,739,487,259
WELLS FARGO & COMPANY/MN 1.3% 7,157,373 -2.1% 0.41% $2,019,810,712
NORTHERN TRUST CORP 1.1% 6,144,480 +0.04% 0.22% $1,733,972,256
BANK OF AMERICA CORP /DE/ 0.96% 5,185,681 -6.9% 0.11% $1,463,399,115
Capital Research Global Investors 0.88% 4,731,290 +2.7% 0.25% $1,335,167,503
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.84% 4,549,298 -14% 0.28% $1,283,811,896
ROYAL BANK OF CANADA 0.84% 4,530,568 -0.13% 0.23% $1,278,525,000
Invesco Ltd. 0.83% 4,467,287 +6.6% 0.2% $1,260,668,311
GOLDMAN SACHS GROUP INC 0.83% 4,446,530 +5.1% 0.18% $1,254,810,759
UBS Group AG 0.79% 4,232,754 -7.5% 0.23% $1,194,483,178
JPMORGAN CHASE & CO 0.79% 4,229,865 +9.4% 0.08% $1,193,700,479
Bank of New York Mellon Corp 0.74% 3,979,186 -0.61% 0.2% $1,122,926,243
Legal & General Group Plc 0.69% 3,716,957 +5% 0.24% $1,048,925,263
Aristotle Capital Management, LLC 0.65% 3,474,491 -4.2% 1.9% $980,527,814
FMR LLC 0.63% 3,404,081 -7.2% 0.05% $960,631,813
DIMENSIONAL FUND ADVISORS LP 0.59% 3,178,590 +5.1% 0.19% $896,842,835
NORDEA INVESTMENT MANAGEMENT AB 0.53% 2,874,403 +0.79% 0.7% $794,456,246

Institutional Holders of AMGEN INC - Common Stock (AMGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 474,077 $155,172,171 +$2,674,051 $327.31 61
2025 Q3 421,944,206 $119,042,096,234 -$2,495,571,983 $282.20 2,776
2025 Q2 431,017,097 $120,366,553,868 +$2,450,274,048 $279.21 2,823
2025 Q1 421,748,142 $131,305,789,445 +$1,867,304,256 $311.55 2,888
2024 Q4 416,539,395 $108,583,275,448 +$3,743,804,618 $260.64 2,799
2024 Q3 400,142,484 $128,873,459,773 -$3,755,805,036 $322.21 2,796
2024 Q2 411,746,351 $128,623,944,471 +$2,316,790,887 $312.45 2,750
2024 Q1 401,986,956 $114,165,831,511 -$2,173,911,569 $284.32 2,690
2023 Q4 2,214,452 $637,763,931 +$164,325,562 $288.02 43
2023 Q3 398,259,214 $107,057,715,599 +$352,991,833 $268.76 2,444
2023 Q2 384,163,380 $85,388,508,682 -$2,233,076,627 $222.02 2,335
2023 Q1 385,363,647 $93,159,490,710 +$148,905,711 $241.75 2,378
2022 Q4 377,138,736 $99,067,211,885 -$1,692,180,328 $262.64 2,442
2022 Q3 408,211,032 $92,099,511,490 -$796,836,181 $225.40 2,262
2022 Q2 412,135,800 $100,260,117,047 -$1,096,227,098 $243.30 2,305
2022 Q1 413,673,141 $100,047,911,465 -$1,227,316,785 $241.82 2,283
2021 Q4 422,641,417 $95,113,975,118 -$606,714,983 $224.97 2,245
2021 Q3 422,939,686 $89,994,006,055 -$1,797,831,508 $212.65 2,096
2021 Q2 431,937,793 $105,257,313,453 -$1,548,212,073 $243.75 2,156
2021 Q1 437,966,104 $108,893,390,306 +$166,294,028 $248.81 2,175
2020 Q4 437,926,781 $100,665,163,874 -$1,539,989,856 $229.92 2,179
2020 Q3 444,871,432 $112,920,377,683 -$1,538,824,708 $254.16 2,091
2020 Q2 433,588,002 $102,263,842,813 +$382,975,286 $235.86 2,060
2020 Q1 445,273,029 $90,357,352,613 -$1,043,055,500 $202.73 1,996
2019 Q4 454,692,092 $109,574,728,301 -$1,394,728,746 $241.07 2,077
2019 Q3 460,093,327 $89,051,180,524 -$452,802,557 $193.51 1,858
2019 Q2 462,272,867 $85,152,351,602 -$796,651,819 $184.28 1,841
2019 Q1 470,588,999 $89,357,608,425 -$2,523,300,640 $189.98 1,850
2018 Q4 491,780,792 $95,645,497,760 -$1,226,154,605 $194.67 1,864
2018 Q3 460,153,342 $95,312,348,939 -$1,289,283,630 $207.29 1,773
2018 Q2 502,214,280 $92,643,591,498 -$3,179,247,442 $184.59 1,737
2018 Q1 526,553,804 $89,704,882,483 -$8,100,451,024 $170.48 1,735
2017 Q4 573,445,145 $99,663,658,848 -$635,927,701 $173.90 1,715
2017 Q3 576,081,802 $107,378,847,785 +$88,193,151 $186.45 1,590
2017 Q2 576,240,008 $99,211,979,836 +$13,268,581 $172.23 1,582
2017 Q1 583,889,772 $95,790,141,175 +$8,261,199,819 $164.07 1,587
2016 Q4 581,417,690 $85,014,213,387 -$2,038,127,491 $146.21 1,525
2016 Q3 593,743,693 $98,981,523,614 -$534,534,405 $166.81 1,502
2016 Q2 596,357,078 $90,751,172,028 -$656,367,084 $152.15 1,457
2016 Q1 600,897,269 $90,078,452,599 -$692,765,942 $149.93 1,422
2015 Q4 606,050,789 $98,338,564,681 -$579,233,327 $162.33 1,448
2015 Q3 609,101,078 $84,251,263,406 +$74,832,362 $138.32 1,366
2015 Q2 598,360,961 $91,869,823,731 -$1,155,840,958 $153.52 1,355
2015 Q1 615,720,757 $98,431,761,556 -$144,923,884 $159.85 1,330
2014 Q4 617,235,572 $98,324,680,975 +$189,312,567 $159.29 1,324
2014 Q3 614,082,374 $86,251,357,852 +$1,591,018,038 $140.46 1,206
2014 Q2 598,994,403 $70,918,316,408 +$174,291,297 $118.37 1,177
2014 Q1 601,681,778 $74,164,633,469 -$950,563,418 $123.34 1,165